Book contents
- Frontmatter
- Contents
- Contributors
- Introduction
- I Critical Concepts
- II Therapeutic Areas
- 10 Oncologic Drugs
- 11 Pharmacogenetics and Pharmacogenomics of Cardiovascular Disease
- 12 Statin-Induced Muscle Toxicity
- 13 Genomics of the Drug-Induced Long-QT Syndrome
- 14 Pharmacogenetics of Diabetes
- 15 Pharmacogenetics – Therapeutic Area – Respiratory
- 16 Pharmacogenomics Associated with Therapy for Acid-Related Disorders
- 17 Pharmacogenetics of Rheumatology: Focus on Rheumatoid Arthritis
- 18 Pharmacogenetics of Obstetric Therapeutics
- 19 Pharmacogenomics of Psychiatric Drugs
- 20 Pain and Anesthesia
- 21 HIV and Antiretroviral Therapy
- 22 Application of Pharmacogenetics and Pharmacogenomics in Pediatrics: What Makes Children Different?
- References
13 - Genomics of the Drug-Induced Long-QT Syndrome
from II - Therapeutic Areas
Published online by Cambridge University Press: 05 June 2012
Book contents
- Frontmatter
- Contents
- Contributors
- Introduction
- I Critical Concepts
- II Therapeutic Areas
- 10 Oncologic Drugs
- 11 Pharmacogenetics and Pharmacogenomics of Cardiovascular Disease
- 12 Statin-Induced Muscle Toxicity
- 13 Genomics of the Drug-Induced Long-QT Syndrome
- 14 Pharmacogenetics of Diabetes
- 15 Pharmacogenetics – Therapeutic Area – Respiratory
- 16 Pharmacogenomics Associated with Therapy for Acid-Related Disorders
- 17 Pharmacogenetics of Rheumatology: Focus on Rheumatoid Arthritis
- 18 Pharmacogenetics of Obstetric Therapeutics
- 19 Pharmacogenomics of Psychiatric Drugs
- 20 Pain and Anesthesia
- 21 HIV and Antiretroviral Therapy
- 22 Application of Pharmacogenetics and Pharmacogenomics in Pediatrics: What Makes Children Different?
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Principles of Pharmacogenetics and Pharmacogenomics , pp. 136 - 144Publisher: Cambridge University PressPrint publication year: 2012
References
Quinidine syncope, paroxysmal ventricular fibrillations occurring during treatment of chronic atrial arrhythmiasCirculation 1964 30 17.Google Scholar
La tachycardie ventriculaire à deux foyers opposés variablesArch Mal Coeur 1966 59 263Google Scholar
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac deathNature 2003 421 634Google Scholar
Defining the cellular phenotype of “ankyrin-B syndrome” variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytesCirculation 2007 115 432Google Scholar
Drug-induced torsades de pointes and implications for drug developmentJ Cardiovasc Electrophysiol 2004 15 475Google Scholar
A mechanistic link between an inherited and an acquired cardiac arrhythmia: encodes the IKr potassium channelCell 1995 81 299Google Scholar
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study GroupN Engl J Med 1999 341 857Google Scholar
Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndromeJ Electrocardiol 1999 32 177Google Scholar
Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle lengthCirc Res 1985 56 857Google Scholar
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugsJAMA 1993 270 2590Google Scholar
Sex hormones prolong the QT interval and down regulate potassium channel expression in the rabbit heartCirculation 1996 94 1471Google Scholar
Extracellular potassium modulation of drug block of IKr: implications for torsades de pointes and reverse use-dependenceCirculation 1996 93 407Google Scholar
Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failureCirc Res 1996 78 262Google Scholar
Increased sensitivity to QT prolonging drug therapy immediately after cardioversion to sinus rhythmJ Am Coll Cardiol 1999 34 396Google Scholar
Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndromeJ Am Coll Cardiol 2008 51 836Google Scholar
A rate-independent method of assessing QT-RR slope following conversion of atrial fibrillationJ Cardiovasc Electrophysiol 2007 18 636Google Scholar
Clinical safety profile of sotalol in patients with arrhythmiasAm J Cardiol 1990 65 74AGoogle Scholar
Common gene variants associated with drug induced long-QT syndromeCirculation 2005 112Google Scholar
Drugs that induce repolarization abnormalities cause bradycardia in zebrafishCirculation 2003 107 1355Google Scholar
Abstract 637: A pharmacogenetic screen for modifiers of drug induced QT prolongation reveals 15 novel genesCirculation 2007 116Google Scholar
Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafishDevelopment 2006 133 3139Google Scholar
Heart of glass regulates the concentric growth of the heart in zebrafishCurr Biol 2003 13 2138Google Scholar
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarizationNat Genet 2006 38 644Google Scholar
CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heartProc Natl Acad Sci USA 2008 105 4477Google Scholar
Taking the idio out of idiosyncratic – predicting torsades de pointesPACE 1998 21 1029Google Scholar
Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome – a case-control pilot study using i.v. sotalolEur Heart J 2003 24 649Google Scholar
KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndromeCirculation 1997 96 2778Google Scholar
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmiasJ Cardiovasc Electrophysiol 2000 11 691Google Scholar
Drug-induced long-QT syndrome associated with a subclinical SCN5A mutationCirculation 2002 106 1269Google Scholar
Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscleCirculation 2005 112 1392Google Scholar
Subunit interaction determines IKs participation in cardiac repolarization and repolarization reserveCirculation 2005 112 1384Google Scholar
Protecting the heart against arrhythmias: potassium current physiology and repolarization reserveCirculation 2005 112 1376Google Scholar
2008
Allelic variants in long QT disease genes in patients with drug-associated Torsades de PointesCirculation 2002 105 1943Google Scholar
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointesHeart Rhythm 2007 4 603Google Scholar
Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patientsJ Mol Med 2004 82 182Google Scholar
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmiaScience 2002 297 1333Google Scholar
A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103YJ Clin Invest 2006 116 430Google Scholar
Association between HERG K897T polymorphism and QT interval in middle-aged Finnish womenJ Am Coll Cardiol 2002 40 511Google Scholar
A common polymorphism in KCNH2 (HERG) hastens cardiac repolarizationCardiovasc Res 2003 59 27Google Scholar
Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart StudyCirculation 2007 116 1128Google Scholar
Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the Old Order AmishHum Hered 2007 64 214Google Scholar
Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam StudyCirculation 2007 116 10Google Scholar
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populationsCirculation 2009 119 940Google Scholar
QT interval prolongation as a predictor of sudden death in patients with myocardial infarctionCirculation 1978 56 1074Google Scholar
Prolonged QTc interval and risk of sudden cardiac death in a population of older adultsJ Am Coll Cardiol 2006 47 362Google Scholar
Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death StudyCirculation 2009 119 663Google Scholar